Project Grant H79TI086404

Award Date 9/30/23
Completion Date 9/29/28
Dollars Obligated $4.2M
Federal Grant Program
93.243
Assistance Type
Project Grant
Place of Performance
Minnesota, USA
Similar Awards
The federal Project Grant award H79TI087171, funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, aims to connect existing prenatal, labor and delivery, postpartum, pediatric, and substance use disorder treatment providers to increase patient engagement, integrated whole-person care, and wraparound services for pregnant and postpartum women with...
The Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, administered by the Substance Abuse and Mental Health Services Administration (SAMHSA), awarded a $892,270 Project Grant to Magnolia Women's Recovery Programs, Inc. The grant will fund a 5-year program to provide residential, gender-specific, family-focused, healing-centered, and trauma-informed treatment for 80 pregnant and parenting women with co-occurring substance use...
This Project Grant award of $240,000 from the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) will enhance family engagement in the behavioral health system for children in Pennsylvania over a three-year period. Key activities include training 30 parents from diverse backgrounds to influence policies and child-serving...
This Project Grant award, provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, will expand the Indiana Pregnancy Promise Program (PROMISE) to serve an additional 300 pregnant individuals with substance use disorder in targeted Indiana counties over the next 3 years. The $894,841 award, effective September 30, 2024, will allow the Indiana...
This federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $945,397 provides funding to the Magee-Womens Research Institute and Foundation, with a sub-award to the University of Pittsburgh, to adapt and evaluate a collaborative care model (CCM) for treating pregnant persons with opioid use disorder (OUD) in low-resource obstetric settings. The key objectives are to: 1) adapt the CCM for rural and low-resource...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $500,000 Project Grant under the Congressional Directives program (CFDA 93.493) to the AIDS Service Center of Lower Manhattan, Inc., doing business as Alliance for Positive Change. The funding will support the "Women Accessing Options for Opioid Management (OPTIONS)" program, which provides comprehensive substance use disorder (SUD) treatment, harm reduction strategies, and recovery support services...
This Project Grant award, totaling $600,000.00, was provided by the Health Resources and Services Administration (HRSA) under the Health Center Program (CFDA 93.224). The grant aims to expand integrated behavioral health services for women and pediatric populations at the Valleywise Health Comprehensive Health Center in Phoenix, Arizona. Key strategies include: Increasing the number of integrated behavioral health clinicians and nurses to serve the mental health and substance use disorder...
The Substance Abuse and Mental Health Services Administration (SAMHSA) has awarded a $900,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Alabama Department of Mental Health's Office of Substance Use Treatment Services. The "Healthy Moms Healthy Babies" project aims to expand family-based outpatient treatment and recovery services for pregnant and postpartum women with substance use...
This $800,000 Project Grant awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program aims to develop a coordinated, comprehensive system serving children birth to age 8 with social/emotional/behavioral challenges in Luzerne and Wyoming Counties, Pennsylvania. The grant funding will be used to screen 1,000 children annually (5,000 over the 5-year grant...
This Project Grant award of $12,000,000 from the U.S. Department of Health and Human Services' Healthcare Systems Bureau under the Congressional Directives program (CFDA 93.493) will enable Meta House, Inc., a non-profit organization in Milwaukee, Wisconsin, to construct a new residential substance use disorder (SUD) treatment facility. This will allow Meta House to expand its capacity from 35 to 100 treatment beds, significantly increasing access to family-centered SUD treatment services for...

STRENGTHENING RESIDENTIAL CARE TO IMPROVE OUTCOMES FOR PREGNANT AND PARENTING WOMEN AND THEIR FAMILIES - WAYSIDE RECOVERY CENTER'S STRENGTHENING RESIDENTIAL CARE TO IMPROVE OUTCOMES FOR PREGNANT AND PARENTING WOMEN AND THEIR FAMILIES PROGRAM WILL INCREASE ACCESS TO FAMILY RESIDENTIAL TREATMENT AND IMPROVE TREATMENT RETENTION FOR LOW-INCOME AND BIPOC PREGNANT AND PARENTING WOMEN AND THEIR CHILDREN AND FAMILIES. THE PROJECT WILL STRENGTHEN WAYSIDE'S COMPREHENSIVE FAMILY RESIDENTIAL TREATMENT MODEL TO ADDRESS INCREASING MENTAL HEALTH NEEDS AND SUD ACUITY AMONG CLIENTS AND THROUGHOUT MINNESOTA. SERVICE ENHANCEMENTS INCLUDE EXPANDED MENTAL HEALTH AND PSYCHOLOGICAL SERVICES, INCREASED CARE COORDINATION FOR MEDICATION ASSISTED TREATMENT (MAT) AND MEDICAL, PERINATAL, AND PEDIATRIC APPOINTMENTS WITH TRANSPORTATION, OUTREACH TO INCARCERATED WOMEN WITH PROJECT SUCCEED CURRICULUM, AND CULTURALLY RELEVANT OVERDOSE AND FAMILY PREVENTION ACTIVITIES. AS A RESULT, WE WILL IMPROVE OUTCOMES FOR 925 WOMEN (150-200 ANNUALLY) AND THEIR 1,675 CHILDREN AND FAMILY MEMBERS (300-350 ANNUALLY) THROUGHOUT THE FIVE-YEAR GRANT TERM. WAYSIDE SPECIALIZES IN SERVING INDIVIDUALS WITH SIGNIFICANT HISTORIES OF SUD AND MENTAL HEALTH DIAGNOSES, TRAUMA, HOMELESSNESS, AND CRIMINAL JUSTICE AND CHILD PROTECTION INVOLVEMENT. ON AVERAGE, MORE THAN 40% OF OUR CLIENTS ENTER TREATMENT PREGNANT AND MORE THAN 70% ENTER WITH DEPENDENT CHILDREN. 47% IDENTIFY AS BLACK, INDIGENOUS, OR A PERSON OF COLOR (BIPOC) INCLUDING 17% INDIGENOUS, 13% AFRICAN AMERICAN, AND 17% BIRACIAL/MULTIRACIAL. OVER 96% OF ALL THE WOMEN WE SERVE ARE MEDICAID ELIGIBLE AND HAVE EXPERIENCED INTERGENERATIONAL POVERTY AND OPPRESSION. WAYSIDE'S PROGRAM GOALS AND MEASURABLE OBJECTIVES ARE TO: 1) INCREASE ACCESS TO INTEGRATED BEHAVIORAL HEALTH SERVICES FOR LOW-INCOME AND BIPOC PREGNANT, POSTPARTUM AND PARENTING WOMEN TO IMPROVE MATERNAL AND INFANT HEALTH OUTCOMES BY PRIORITIZING ADMISSION OF PREGNANT WOMEN ON THE WAIT LIST; EXPANDING TRANSPORTATION CAPACITY TO AND FROM MAT DOSING; INCREASING ACCESS TO MENTAL HEALTH SERVICES BY 33%; AND INCREASING MEDICAL CARE COORDINATION TO SUPPORT TOXIN-FREE BIRTHS; 2) IMPROVE FAMILY STABILIZATION BY PROVIDING EVIDENCE-BASED INTERVENTIONS AND CULTURALLY-SPECIFIC WRAPAROUND SUPPORTS, CPS NAVIGATION TO REUNIFY FAMILIES AND PREVENT RECIDIVISM, AND 1:1 CASE MANAGEMENT AND PEER SUPPORT; 3) IMPROVE TREATMENT RETENTION AND INCREASE SUCCESSFUL COMPLETIONS AMONG PREGNANT AND PARENTING WOMEN BY INCREASING ACCESS TO ADULT AND CHILDREN'S MENTAL HEALTH SERVICES BY 50%; DELIVERING OVERDOSE EDUCATION AND NALOXONE TO THE COMMUNITY, AND CONDUCTING OUTREACH TO INCARCERATED WOMEN WITH PROJECT SUCCEED CURRICULUM; AND 4) MITIGATE THE EFFECTS OF PARENTAL SUBSTANCE USE AND ADVERSE EXPERIENCES WITH EARLY INTERVENTION AND DEVELOPMENTAL SUPPORT INCLUDING NEUROPSYCHOLOGICAL EVALUATIONS, PRENATAL ALCOHOL EXPOSURE SCREENING AND FASD EDUCATION, DEVELOPMENTAL AND MENTAL HEALTH ASSESSMENTS AND REFERRALS AND INCREASED PEDIATRIC CARE COORDINATION FOR PRENATAL EXPOSURE TO SUBSTANCES. IN 2009, WAYSIDE WAS THE FIRST IN MINNESOTA TO PROVIDE FAMILY RESIDENTIAL TREATMENT. TODAY WE REMAIN ONE OF ONLY THREE PROVIDERS IN THE STATE AND CONTINUE TO LEAD ADVANCEMENTS IN FAMILY SERVICE MODELS THAT STABILIZE FAMILIES AND REDUCE TRANSMISSION OF RISK FOR SUD AND TRAUMA IN FUTURE GENERATIONS. FOR THE PAST 15 YEARS WE HAVE WORKED WITH THE MINNESOTA DEPARTMENT OF HUMAN SERVICES TO PROVIDE CARE AND EVALUATE OUTCOMES FOR PREGNANT, POSTPARTUM AND PARENTING MOTHERS WITH SUD/COD AND THEIR FAMILIES. IN THAT TIME, WE HAVE GROWN TO SERVE NEARLY 70% OF ALL PREGNANT AND PARENTING WOMEN ACCESSING RESIDENTIAL TREATMENT THROUGHOUT THE STATE, IMPROVING THE HEALTH, SAFETY AND STABILITY OF HUNDREDS OF WOMEN AND CHILDREN EACH YEAR.

Posted 7/24/23, 12:00 AM